Parasitic infections remain a major cause of morbidity and mortality worldwide. The vast majority of infections in humans and domestic animals can be attributed to protozoan pathogens responsible for malaria, African trypanosomiasis (sleeping sickness, nagana, etc), leishmaniasis and toxoplasmosis. In addition, parasitic infections kill millions of livestock, which strongly affect rural development and poverty alleviation in developing countries (as an example, estimation of economic losses caused by African trypanosomoses is US$ 4.75 billion per year). ParaFrap in a joint effort with industrial partners aims to improve the health situation disease endemic countries.
To favor the transfer to the economic world, ParaFrap will reinforce its ongoing connections with industrial partners, including Sanofi-Aventis, Novartis, Virbac, CEVA Santé Animale, and a number of Small & Medium Enterprise. A number of projects are already supported by patents and we anticipate that most of the new collaborative projects stimulated by ParaFrap will generate innovation and numerous new patents that will be developed in close collaboration with industrial partners linked to ParaFrap for commercial exploitation. An industry representative will be involved in the governance (Executive Committee) to facilitate and stimulate collaborative research between industrial and academic partners.
The ParaFrap website is created with a public section to create awareness for the consortium activities including updates and announcements of major break through results of the consortium in basic research and new intervention strategies. In addition, an informative section will be created with facts about major parasitic diseases and their treatment. This will include the creation of a database of experts in parasitology (including contact address). The web site also will be an excellent communication tool between consortium members (announcement of workshops, PhD program etc.). A major impact on the creation of new jobs will be an important secondary effect of this LabEx. ParaFrap will create highly competitive PhD program with 20 well-trained students and 20 post docs. At the end of their training, we will promote their integration in industry research programs (through existing partnership with private company or through the Sup’Biotech Engineer School connections) or alternatively assist them in finding excellent postdoc positions in leading international institutions. ParaFrap participants have excellent international connections through the organization of international conferences and workshops. We will help excellent post docs and young group leaders to integrate into one of the French Institutions (staff position). Taken together, ParaFrap will promote a highly competitive industry research on parasitology that should feed back on creating a number of new jobs. This environment will be very favorable for innovative research and the creation of new start up companies. A good example is Man Ros Therapeutics that has been recently created by a CNRS scientist.
The York Biomedical Research Institute (YBRI) are hosting an online live seminar on Friday 24th May 1-2pm BST as part of their biomedical science seminar series. You are all welcome to attend - registration is required via the...
[Communiqué] Congratulations to Arthur Talman, IRD Research Leader in the MIVEGEC laboratory (Montpellier), who has been awarded an Advanced Grant from the European Research Council (ERC) for the project "TROJAN - Molecular mimicry and immune...
Ana Rita Gomes, a CNRS Research Associate at the Laboratory of Pathogens and Host Immunity in Montpellier, and former Postdoctoral fellow of the LabEx ParaFrap, has been awarded the prestigious CNRS Bronze Medal in 2023. This...
. PhD Opportunity, Tours, France Supervision Thesis Supervisor: Sonia LAMANDE; Co-Supervisor: Julie TOTTEY Project: FUNTIONAL CHARACTERISATION OF CYSTEINE CATHEPSINS IN THE APICOMPLEXAN PARASITE CRYPTOSPORIDIUM...
Senior PostDoc position : computational biologist, Paris, France The ParSig team (https://research.pasteur.fr/en/team/molecular-parasitology-and-signaling) at the Institut Pasteur in Paris seeks for a highly...
Researcher in Livestock Immunology for the Study of Animal Trypanosomoses Through a One Health approach, the Intertryp Joint Research Unit (Cirad-IRD) is developing research on interactions between hosts,...
Happy New Year 2024! To kick off this new scientific year, here is the ParaFrap webinar schedule. Since January 2021, ParaFrap has been organizing a series of webinars. This monthly event, held every 2nd Thursday of the month, aims to strengthen...
PostDoc position : functional analysis of P. falciparum early gametocyte proteins, Allschwil, Switzerland The Malaria Gene Regulation Lab of Till Voss is looking for a highly motivated and talented postdoc to...
The team of Dr. Mohamed-Ali Hakimi, in collaboration with Isabelle Coppens (Johns Hopkins University Bloomberg School of Public Health and Malaria Research Institute, Baltimore, MD, USA), has developed a new (epi)genetic method to produce in vitro...
Success for ParaFrap students at MPM2023 Parafrap students won numerous awards at the MPM 2023, Woods Hole USA, 17-21 September 2023. A warm congratulations to all ! Parul Sharma (2nd year PhD under the...
© 2023. All rights reserved MLCOM
Notre site LabEx ParaFrap utilise des cookies pour réaliser des statistiques de visites, partager des contenus sur les réseaux sociaux et améliorer votre expérience. En refusant les cookies, certains services seront amenés à ne pas fonctionner correctement. Nous conservons votre choix pendant 30 jours. Vous pouvez changer d'avis en cliquant sur le bouton 'Cookies' en bas à gauche de chaque page de notre site. En savoir plus
Ce site utilise des cookies pour assurer son bon fonctionnement et ne peuvent pas être désactivés de nos systèmes. Nous ne les utilisons pas à des fins publicitaires. Si ces cookies sont bloqués, certaines parties du site ne pourront pas fonctionner.
Ce site utilise des cookies de mesure et d’analyse d’audience, tels que Google Analytics et Google Ads, afin d’évaluer et d’améliorer notre site internet.
Ce site utilise des composants tiers, tels que NotAllowedScript662bfdb14bb1aReCAPTCHA, Google NotAllowedScript662bfdb14b6d2Maps, MailChimp ou Calameo, qui peuvent déposer des cookies sur votre machine. Si vous décider de bloquer un composant, le contenu ne s’affichera pas
Des plug-ins de réseaux sociaux et de vidéos, qui exploitent des cookies, sont présents sur ce site web. Ils permettent d’améliorer la convivialité et la promotion du site grâce à différentes interactions sociales.
Ce site web utilise un certain nombre de cookies pour gérer, par exemple, les sessions utilisateurs.